Clinical Trials
9 trialsNCT00082797 2023-06-15
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00068250 2018-02-07
Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT00084838 2015-12-24
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00416819 2015-08-20
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
University of California, San Francisco
Phase NA Completed
NCT00303810 2014-01-28
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
Universitätsklinikum Hamburg-Eppendorf
Phase NA Completed
NCT00006258 2013-07-18
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00513981 2013-06-26
High-Dose Methotrexate in Treating Young Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00463008 2013-06-24
Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma
National Cancer Institute (NCI)
Phase NA Completed
NCT00002463 2013-02-18
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
M.D. Anderson Cancer Center
Phase 2 Completed